The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Monopost Unidose 50 micrograms/ml eye drops, solution in single-dose container



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/029/001

Main Information

Trade NameMonopost Unidose 50 micrograms/ml eye drops, solution in single-dose container
Active SubstancesLatanoprost
Dosage FormEye drops, solution in single-dose container
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/029/001

Group Information

ATC CodeS01EE Prostaglandin analogues1)
S01EE01 latanoprost

Status

License statusAuthorised
Licence Issued10/07/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0096-152-059
Interchangeable List DocumentPDF of Interchangeable List
« Back